NASDAQ : RLAY
Relay Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 19.47 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 4.27B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Relay Therapeutics, Inc. (RLAY) reported revenue of 10.35M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 10.35M | 15.36M | 10.01M | 25.55M | 1.38M | 3.03M |
| Cost of Revenue | 268.85M | 257.21M | 315.44M | 326.39M | 243.00M | 169.39M |
| Gross Profit | -258.50M | -241.85M | -305.43M | -300.84M | -241.62M | -166.36M |
| Selling, General & Admin | 51.94M | 58.59M | 80.24M | 78.58M | 69.33M | 59.75M |
| Operating Expenses | 51.94M | 58.59M | 80.24M | 78.58M | 69.33M | 59.75M |
| Operating Income | -310.44M | -300.44M | -385.67M | -379.42M | -310.95M | -226.11M |
| Interest & Investment Income | 24.58M | 27.04M | 34.75M | 31.05M | 8.79M | 830.00K |
| Other Non Operating Income (Expenses) | -186.00K | -776.00K | 14.00K | -18.00K | -20.00K | -4.00K |
| EBT Excluding Unusual Items | -286.04M | -274.18M | -350.91M | -348.39M | -302.19M | -225.28M |
| Merger & Restructuring Charges | -900.00K | |||||
| Gain (Loss) on Sale of Investments | -11.86M | |||||
| Asset Writedown | -2.30M | |||||
| Other Unusual Items | 13.21M | 6.42M | 11.68M | -2.84M | ||
| Pretax Income | -286.04M | -276.48M | -337.71M | -341.97M | -290.51M | -363.87M |
| Net Income | -286.04M | -276.48M | -337.71M | -341.97M | -290.51M | -363.87M |
| Net Income to Common | -286.04M | -276.48M | -337.71M | -341.97M | -290.51M | -363.87M |
| Shares Outstanding (Basic) | 182.17M | 171.59M | 142.87M | 122.58M | 112.23M | 95.14M |
| Shares Outstanding (Diluted) | 182.17M | 171.59M | 142.87M | 122.58M | 112.23M | 95.14M |
| EPS (Basic) | -1.57 | -1.61 | -2.36 | -2.79 | -2.59 | -3.82 |
| EPS (Diluted) | -1.57 | -1.61 | -2.36 | -2.79 | -2.59 | -3.82 |
| Free Cash Flow | -212.21M | -235.87M | -251.12M | -304.44M | -238.55M | -77.88M |
| Free Cash Flow Per Share | -1.17 | -1.38 | -1.76 | -2.48 | -2.12 | -0.82 |
| Operating Margin | -2,999.37% | -1,956.61% | -3,854.04% | -1,485.25% | -22,516.44% | -7,464.74% |
| Profit Margin | -2,763.64% | -1,800.58% | -3,374.72% | -1,338.66% | -21,036.13% | -12,012.94% |
| Free Cash Flow Margin | -2,050.29% | -1,536.08% | -2,509.49% | -1,191.74% | -17,273.86% | -2,571.05% |
| EBITDA | -308.22M | -296.88M | -380.21M | -374.15M | -306.82M | -222.18M |
| D&A For EBITDA | 2.21M | 3.56M | 5.46M | 5.27M | 4.13M | 3.92M |
| EBIT | -310.44M | -300.44M | -385.67M | -379.42M | -310.95M | -226.11M |
| Revenue as Reported | 10.35M | 15.36M | 10.01M | 25.55M | 1.38M | 3.03M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 121.19M | 84.02M | 124.29M | 143.74M | 151.79M | 280.12M |
| Short-Term Investments | 789.75M | 470.50M | 657.04M | 606.35M | 847.12M | 677.95M |
| Cash & Short-Term Investments | 910.93M | 554.52M | 781.32M | 750.09M | 998.92M | 958.07M |
| Receivables | 5.22M | 4.94M | ||||
| Prepaid Expenses | 8.73M | 17.79M | 17.35M | 16.70M | 12.11M | 11.46M |
| Other Current Assets | 8.41M | 5.97M | 10.53M | 3.31M | 3.26M | 1.76M |
| Total Current Assets | 928.08M | 578.28M | 809.20M | 770.10M | 1.02B | 976.24M |
| Property, Plant & Equipment | 38.04M | 41.72M | 57.67M | 68.87M | 75.39M | 27.32M |
| Other Intangible Assets | 2.30M | 2.30M | 2.30M | 2.30M | ||
| Other Long-Term Assets | 1.34M | 1.34M | 2.12M | 2.71M | 2.58M | 2.58M |
| Total Assets | 967.46M | 621.33M | 871.30M | 843.98M | 1.10B | 1.01B |
| Accounts Payable | 11.46M | 7.71M | 14.10M | 9.21M | 10.58M | 8.28M |
| Accrued Expenses | 34.08M | 13.64M | 21.24M | 14.89M | 22.70M | 13.56M |
| Current Portion of Leases | 4.01M | 3.77M | 5.73M | 4.96M | 4.28M | 1.84M |
| Current Unearned Revenue | 7.68M | 248.00K | ||||
| Other Current Liabilities | 1.25M | 463.00K | 1.99M | 1.20M | 26.15M | 396.00K |
| Total Current Liabilities | 50.80M | 25.58M | 50.73M | 30.27M | 63.71M | 24.32M |
| Long-Term Leases | 26.64M | 28.69M | 42.77M | 48.50M | 53.47M | 21.06M |
| Other Long-Term Liabilities | 13.21M | 32.38M | 65.26M | |||
| Total Liabilities | 77.45M | 54.27M | 93.50M | 91.98M | 149.55M | 110.64M |
| Common Stock | 211.00K | 168.00K | 168.00K | 127.00K | 121.00K | 109.00K |
| Additional Paid-In Capital | 3.06B | 2.58B | 2.52B | 2.15B | 2.02B | 1.67B |
| Retained Earnings | -2.17B | -2.01B | -1.74B | -1.40B | -1.06B | -768.10M |
| Comprehensive Income & Other | -1.55M | 733.00K | -991.00K | -196.00K | -10.42M | -1.09M |
| Total Common Equity | 890.01M | 567.06M | 777.79M | 752.00M | 950.22M | 897.81M |
| Shareholders' Equity | 890.01M | 567.06M | 777.79M | 752.00M | 950.22M | 897.81M |
| Total Liabilities & Equity | 967.46M | 621.33M | 871.30M | 843.98M | 1.10B | 1.01B |
| Total Debt | 30.66M | 32.46M | 48.50M | 53.47M | 57.74M | 22.90M |
| Net Cash (Debt) | 880.28M | 522.06M | 732.82M | 696.62M | 941.17M | 935.17M |
| Net Cash Per Share | 4.83 | 3.04 | 5.13 | 5.68 | 8.39 | 9.83 |
| Filing Date Shares Outstanding | 219.14M | 178.73M | 169.52M | 131.18M | 121.38M | 108.28M |
| Total Common Shares Outstanding | 218.53M | 173.87M | 167.76M | 127.46M | 121.11M | 108.21M |
| Working Capital | 877.28M | 552.70M | 758.48M | 739.83M | 955.80M | 951.92M |
| Book Value Per Share | 4.07 | 3.26 | 4.64 | 5.90 | 7.85 | 8.30 |
| Tangible Book Value | 890.01M | 567.06M | 775.49M | 749.70M | 947.92M | 895.51M |
| Tangible Book Value Per Share | 4.07 | 3.26 | 4.62 | 5.88 | 7.83 | 8.28 |
| Machinery | 22.36M | 30.93M | 29.08M | 24.98M | 17.88M | |
| Construction In Progress | 69.00K | 1.58M | 1.22M | 134.00K | ||
| Leasehold Improvements | 908.00K | 3.83M | 3.83M | 3.83M | 2.90M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -286.04M | -276.48M | -337.71M | -341.97M | -290.51M | -363.87M |
| Depreciation & Amortization | 2.21M | 3.56M | 5.46M | 5.27M | 4.13M | 3.92M |
| Loss (Gain) From Sale of Assets | 388.00K | 1.00M | ||||
| Asset Writedown & Restructuring Costs | 2.30M | 123.00M | ||||
| Loss (Gain) From Sale of Investments | -3.36M | -4.95M | -12.42M | -10.76M | 1.18M | 13.91M |
| Stock-Based Compensation | 48.31M | 62.42M | 94.14M | 86.03M | 56.14M | 48.45M |
| Other Operating Activities | -13.21M | -6.42M | -11.68M | 2.84M | ||
| Change in Accounts Receivable | 5.22M | -279.00K | 77.79M | |||
| Change in Accounts Payable | 17.15M | -11.44M | 10.27M | -9.59M | 11.29M | 930.00K |
| Change in Unearned Revenue | -7.68M | 7.68M | -248.00K | |||
| Change in Other Net Operating Assets | 9.14M | -4.19M | -3.33M | -28.09M | 484.00K | 18.62M |
| Operating Cash Flow | -212.21M | -235.46M | -249.11M | -300.32M | -229.49M | -74.41M |
| Capital Expenditures | -410.00K | -2.02M | -4.13M | -9.06M | -3.47M | |
| Cash Acquisitions | -25.30M | |||||
| Investment in Securities | -244.94M | 193.21M | -39.06M | 261.76M | -179.68M | -450.74M |
| Investing Cash Flow | -244.94M | 192.80M | -41.08M | 257.63M | -188.75M | -479.51M |
| Issuance of Common Stock | 463.47M | 1.60M | 270.15M | 34.75M | 289.91M | 388.09M |
| Financing Cash Flow | 463.47M | 1.60M | 270.15M | 34.75M | 289.91M | 388.09M |
| Net Cash Flow | 6.33M | -41.05M | -20.04M | -7.93M | -128.32M | -165.83M |
| Free Cash Flow | -212.21M | -235.87M | -251.12M | -304.44M | -238.55M | -77.88M |
| Free Cash Flow Margin | -2,050.29% | -1,536.08% | -2,509.49% | -1,191.74% | -17,273.86% | -2,571.05% |
| Free Cash Flow Per Share | -1.17 | -1.38 | -1.76 | -2.48 | -2.12 | -0.82 |
| Levered Free Cash Flow | -119.24M | -141.28M | -131.63M | -183.52M | -108.60M | -8.17M |
| Unlevered Free Cash Flow | -119.24M | -141.28M | -131.63M | -183.52M | -108.60M | -8.17M |
| Change in Working Capital | 26.29M | -23.31M | 14.62M | -32.46M | 11.25M | 97.34M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 4.02B | 1.47B | 689.62M | 1.36B | 1.81B | 3.32B |
| Enterprise Value | 3.14B | 903.21M | -100.18M | 601.17M | 812.66M | 2.72B |
| Last Close Price | 18.35 | 8.46 | 4.12 | 11.01 | 14.94 | 30.71 |
| PS Ratio | 388.53 | 95.49 | 68.91 | 53.13 | 1,307.87 | 1,095.42 |
| PB Ratio | 4.51 | 2.59 | 0.89 | 1.80 | 1.90 | 3.70 |
| P/TBV Ratio | 4.52 | 2.59 | 0.89 | 1.81 | 1.91 | 3.71 |
| EV/Sales Ratio | 303.48 | 58.82 | 23.53 | 588.46 | 899.58 | |
| Debt / Equity Ratio | 0.03 | 0.06 | 0.06 | 0.07 | 0.06 | 0.03 |
| Net Debt / Equity Ratio | -0.99 | -0.92 | -0.94 | -0.93 | -0.99 | -1.04 |
| Net Debt / EBITDA Ratio | 2.86 | 1.76 | 1.93 | 1.86 | 3.07 | 4.21 |
| Net Debt / FCF Ratio | 4.15 | 2.21 | 2.92 | 2.29 | 3.94 | 12.01 |
| Asset Turnover | 0.01 | 0.02 | 0.01 | 0.03 | 0.00 | 0.00 |
| Quick Ratio | 17.93 | 21.68 | 15.40 | 24.78 | 15.76 | 39.60 |
| Current Ratio | 18.27 | 22.61 | 15.95 | 25.44 | 16.00 | 40.14 |
| Return on Equity (ROE) | -36.77% | -41.12% | -44.15% | -40.18% | -31.44% | -43.81% |
| Return on Assets (ROA) | -22.88% | -25.16% | -28.11% | -24.40% | -18.44% | -15.63% |
| Return on Capital Employed (ROCE) | -33.90% | -50.40% | -47.00% | -46.60% | -30.00% | -23.00% |
| Earnings Yield | -8.56% | -18.86% | -48.97% | -25.20% | -16.08% | -10.97% |
| FCF Yield | -5.28% | -16.09% | -36.41% | -22.43% | -13.21% | -2.35% |
| Buyback Yield / Dilution | -12.39% | -20.10% | -16.55% | -9.21% | -17.97% | -123.22% |